Ładuje się......
Targeting ERα degradation by L-Tetrahydropalmatine provides a novel strategy for breast cancer treatment
The incidence and mortality of breast cancer (BCa) are the highest among female cancers. There are approximate 70% BCa that are classified as estrogen receptor alpha (ERα) positive. Therefore, targeting ERα is the most significantly therapeutic schedule. However, patients with breast cancer develop...
Zapisane w:
| Wydane w: | Int J Biol Sci |
|---|---|
| Główni autorzy: | , , , , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Ivyspring International Publisher
2020
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7294940/ https://ncbi.nlm.nih.gov/pubmed/32549765 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijbs.44005 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|